Skip to main content

plain-language-summary

Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.

소스 정보

저장소
K-Dense-AI/skill-101-webinar
최근 소스 활동
2026년 7월 7일 00:19
감지된 SKILL.md 언어
영어
스타
8
포크
5

설치 방법

기본적으로 소스를 먼저 확인하는 Prompt가 선택됩니다. 직접 명령으로 전환하거나 로컬 사본을 다운로드할 수도 있습니다.

소스 파일 검토

설치 여부를 결정하기 전에 SKILL.md와 SkillsMP에 표시된 보조 파일을 읽어 보세요.

SKILL.md 표시 중

SKILL.md
소스 지침 · 읽기 전용 미리보기
name
plain-language-summary
description
Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.
# Plain-Language Summary ## When to use Any time the user wants technical, jargon-heavy, or dense material made clear for a general reader — abstracts, documentation, reports, emails, papers. ## Output format (ALWAYS use exactly this) **TL;DR:** one plain sentence anyone could understand. **Why it matters:** 1–2 sentences on the real-world significance. **Key points:** - 3–5 bullets, each jargon-free and self-contained. **Caveats:** what's uncertain, assumed, or out of scope (1–2 bullets). ## Rules - No jargon without a 3-word plain explanation in parentheses. - Prefer everyday words; cut filler. - Keep the whole thing under ~200 words unless the user asks for more. - Never invent facts that aren't in the source text; if something is unclear, say so in Caveats. ## Example Input: "We employed a randomized double-blind placebo-controlled trial (n=240) to assess the efficacy of compound X on LDL-C reduction over 12 weeks." Output: **TL;DR:** A careful study tested whether drug X lowers "bad" cholesterol, and it did. **Why it matters:** Lower bad cholesterol usually means lower heart-disease risk. **Key points:** - 240 people took part over 12 weeks. - Neither patients nor doctors knew who got the real drug (double-blind), which reduces bias. - Some got a fake pill (placebo) for comparison. **Caveats:** - 12 weeks is short — long-term effects aren't shown here.
GitHub에서 보기